{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:35:09Z","timestamp":1790760909661,"version":"4.1.0"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Pulmonary hypertension (PH) and right ventricular (RV) dysfunction are major complications in cardiac surgery. Intraoperative management of patients at high risk of RV failure should aim to reduce RV afterload and optimize RV filling pressures, while avoiding systemic hypotension, to facilitate weaning from cardiopulmonary bypass (CPB). Inhaled epoprostenol and inhaled milrinone (iE&amp;iM) administered in combination before CPB may represent an effective strategy to facilitate separation from CPB and reduce requirements for intravenous inotropes during cardiac surgery. Our primary objective was to report the rate of positive pulmonary vasodilator response to iE&amp;iM and, second, how it relates to perioperative outcomes in cardiac surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>This is a retrospective cohort study of consecutive patients with PH or RV dysfunction undergoing on-pump cardiac surgery at the Montreal Heart Institute from July 2013 to December 2018 (n = 128). iE&amp;iM treatment was administered using an ultrasonic mesh nebulizer before the initiation of CPB. Demographic and baseline clinical data, as well as hemodynamic, intraoperative, and echocardiographic data, were collected using electronic records. An increase of 20% in the mean arterial pressure (MAP) to mean pulmonary artery pressure (MPAP) ratio was used to indicate a positive response to iE&amp;iM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      In this cohort, 77.3% of patients were responders to iE&amp;iM treatment. Baseline systolic pulmonary artery pressure (SPAP) (odds ratio [OR], 1.63; 95% confidence interval [CI], 1.24\u20132.16 per 5 mm Hg;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .0006) was found to be a predictor of pulmonary vasodilator response, while a European System for Cardiac Operative Risk Evaluation (EuroSCORE II) score &gt;6.5% was a predictor of nonresponse to treatment (\u22646.5% vs &gt;6.5% [reference]: OR, 5.19; 95% CI, 1.84\u201314.66;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .002). Severity of PH was associated with a positive response to treatment, where a higher proportion of responders had MPAP values &gt;30 mm Hg (42.4% responders vs 24.1% nonresponders;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .0237) and SPAP values &gt;55 mm Hg (17.2% vs 3.4%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .0037). Easier separation from CPB was also associated with response to iE&amp;iM treatment (69.7% vs 58.6%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .0181). A higher proportion of nonresponders had a very difficult separation from CPB and required intravenous inotropic drug support compared to responders, for whom easy separation from CPB was more frequent. Use of intravenous inotropes after CPB was lower in responders to treatment (8.1% vs 27.6%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .0052).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>A positive pulmonary vasodilator response to treatment with a combination of iE&amp;iM before initiation of CPB was observed in 77% of patients. Higher baseline SPAP was an independent predictor of pulmonary vasodilator response, while EuroSCORE II &gt;6.5% was a predictor of nonresponse to treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000006192","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T09:32:20Z","timestamp":1663579940000},"page":"282-294","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":21,"title":["Pulmonary Vasodilator Response of Combined Inhaled Epoprostenol and Inhaled Milrinone in Cardiac Surgical Patients"],"prefix":"10.1213","volume":"136","author":[{"given":"Mahsa","family":"Elmi-Sarabi","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Montreal Heart Institute, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Jarry","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Montreal Heart Institute, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne J.","family":"Couture","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Department of Medicine, Division of Intensive Care Medicine, Institut Universitaire de Cardiologie et de Pneumologie de Qu\u00e9bec, Universit\u00e9 Laval, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Haddad","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Cogan","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Montreal Heart Institute, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Sweatt","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy and Critical Care Medicine, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Rousseau-Saine","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Montreal Heart Institute, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Beaubien-Souligny","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM) and Innovation Hub, Research Centre CHUM, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annik","family":"Fortier","sequence":"additional","affiliation":[{"name":"Department of Statistics, Montreal Health Innovations Coordinating Center, Montreal Heart Institute, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Y.","family":"Denault","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Montreal Heart Institute, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada"},{"name":"Division of Critical Care, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,9,19]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1053\/j.jvca.2017.02.008","article-title":"Right ventricular function after cardiac surgery is a strong independent predictor for long-term mortality.","volume":"31","author":"Bootsma","year":"2017","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1053\/j.jvca.2018.10.011","article-title":"Preexisting right ventricular dysfunction is associated with higher postoperative cardiac complications and longer hospital stay in high-risk patients undergoing nonemergent major vascular surgery.","volume":"33","author":"Chou","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1053\/j.jvca.2013.01.023","article-title":"Tezosentan and right ventricular failure in patients with pulmonary hypertension undergoing cardiac surgery: the TACTICS trial.","volume":"27","author":"Denault","year":"2013","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1007\/s12630-016-0709-8","article-title":"A multicentre randomized-controlled trial of inhaled milrinone in high-risk cardiac surgical patients.","volume":"63","author":"Denault","year":"2016","journal-title":"Can J Anaesth"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jcmg.2014.12.003","article-title":"Pulmonary hypertension in valvular disease: a comprehensive review on pathophysiology to therapy from the HAVEC Group.","volume":"8","author":"Magne","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"e578","DOI":"10.1161\/CIR.0000000000000560","article-title":"Evaluation and management of right-sided heart failure: a scientific statement from the American Heart Association.","volume":"137","author":"Konstam","year":"2018","journal-title":"Circulation"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1213\/ANE.0000000000002138","article-title":"Aerosolized vasodilators for the treatment of pulmonary hypertension in cardiac surgical patients: a systematic review and meta-analysis.","volume":"125","author":"Elmi-Sarabi","year":"2017","journal-title":"Anesth Analg"},{"key":"R8-20250502","first-page":"1","article-title":"Pilot randomized controlled trial of inhaled milrinone in high-risk cardiac surgical patients.","volume":"4","author":"Denault","year":"2014","journal-title":"Surgery Curr Res"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s12630-019-01309-8","article-title":"Effect of iloprost inhalation on postoperative outcome in high-risk cardiac surgical patients: a prospective randomized-controlled multicentre trial (ILOCARD).","volume":"66","author":"Winterhalter","year":"2019","journal-title":"Can J Anaesth"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1053\/j.jvca.2012.10.017","article-title":"Inhaled milrinone and epoprostenol in a patient with severe pulmonary hypertension, right ventricular failure, and reduced baseline brain saturation value from a left atrial myxoma.","volume":"28","author":"St-Pierre","year":"2014","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1213\/XAA.0000000000000572","article-title":"Point-of-care ultrasonography to assess portal vein pulsatility and the effect of inhaled milrinone and epoprostenol in severe right ventricular failure: a report of 2 cases.","volume":"9","author":"Tremblay","year":"2017","journal-title":"A A Case Rep"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1213\/XAA.0000000000000886","article-title":"Noninvasive administration of inhaled epoprostenol and inhaled milrinone in extubated, spontaneously breathing patients with right ventricular failure and portal hypertension: a report of 2 cases.","volume":"12","author":"Couture","year":"2019","journal-title":"A A Pract"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/j.jvca.2014.06.012","article-title":"Preliminary experience with combined inhaled milrinone and prostacyclin in cardiac surgical patients with pulmonary hypertension.","volume":"29","author":"Laflamme","year":"2015","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1213\/ANE.0000000000004793","article-title":"Routine intraoperative inhaled milrinone and iloprost reduces inotrope use in patients undergoing cardiac surgery: a retrospective cohort pilot study.","volume":"131","author":"Hu","year":"2020","journal-title":"Anesth Analg"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/j.jvca.2013.05.028","article-title":"Effects of early inhaled epoprostenol therapy on pulmonary artery pressure and blood loss during LVAD placement.","volume":"28","author":"Groves","year":"2014","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.ejcts.2007.02.019","article-title":"Preliminary experience with inhaled milrinone in cardiac surgery.","volume":"31","author":"Lamarche","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jtcvs.2003.09.056","article-title":"Inhaled prostacyclin reduces cardiopulmonary bypass-induced pulmonary endothelial dysfunction via increased cyclic adenosine monophosphate levels.","volume":"128","author":"Fortier","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jtcvs.2004.09.011","article-title":"Inhaled but not intravenous milrinone prevents pulmonary endothelial dysfunction after cardiopulmonary bypass.","volume":"130","author":"Lamarche","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000332411","article-title":"Preoperative inhalation of milrinone attenuates inflammation in patients undergoing cardiac surgery with cardiopulmonary bypass.","volume":"21","author":"Gong","year":"2012","journal-title":"Med Princ Pract"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.cjca.2019.04.006","article-title":"Portal hypertension is associated with congestive encephalopathy and delirium after cardiac surgery.","volume":"35","author":"Benkreira","year":"2019","journal-title":"Can J Cardiol"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1053\/j.jvca.2019.12.042","article-title":"Preliminary experience using diastolic right ventricular pressure gradient monitoring in cardiac surgery.","volume":"34","author":"Gr\u00f8nlykke","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R22-20250502","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12630-019-01507-4","article-title":"Guidelines to the practice of anesthesia - revised edition 2020.","volume":"67","author":"Dobson","year":"2020","journal-title":"Can J Anaesth"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"S459","DOI":"10.1016\/j.cjca.2014.09.029","article-title":"Innovative approaches in the perioperative care of the cardiac surgical patient in the operating room and intensive care unit.","volume":"30","author":"Denault","year":"2014","journal-title":"Can J Cardiol"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","article-title":"2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).","volume":"46","author":"Gali\u00e8","year":"2015","journal-title":"Eur Respir J"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/bja\/81.6.945","article-title":"Pulmonary artery catheterization in anaesthesia and intensive care.","volume":"81","author":"G\u00f3mez","year":"1998","journal-title":"Br J Anaesth"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1053\/j.jvca.2005.11.018","article-title":"Importance of relative pulmonary hypertension in cardiac surgery: the mean systemic-to-pulmonary artery pressure ratio.","volume":"20","author":"Robitaille","year":"2006","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R27-20250502","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","article-title":"Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography.","volume":"23","author":"Rudski","year":"2010","journal-title":"J Am Soc Echocardiogr"},{"key":"R28-20250502","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1053\/j.jvca.2018.08.198","article-title":"Perioperative right ventricular pressure monitoring in cardiac surgery.","volume":"33","author":"Raymond","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R29-20250502","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/ejcts\/ezs043","article-title":"EuroSCORE II.","volume":"41","author":"Nashef","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"R30-20250502","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1053\/j.jvca.2015.01.011","article-title":"Right ventricular depression after cardiopulmonary bypass for valvular surgery.","volume":"29","author":"Denault","year":"2015","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R31-20250502","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1038\/s41598-020-58902-x","article-title":"Inhaled milrinone in cardiac surgical patients: a pilot randomized controlled trial of jet vs. mesh nebulization.","volume":"10","author":"Nguyen","year":"2020","journal-title":"Sci Rep"},{"key":"R32-20250502","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1213\/ANE.0000000000005537","article-title":"Transgastric abdominal ultrasonography in anesthesia and critical care: review and proposed approach.","volume":"133","author":"Denault","year":"2021","journal-title":"Anesth Analg"},{"key":"R33-20250502","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bja.2018.09.028","article-title":"High postoperative portal venous flow pulsatility indicates right ventricular dysfunction and predicts complications in cardiac surgery patients.","volume":"122","author":"Eljaiek","year":"2019","journal-title":"Br J Anaesth"},{"key":"R34-20250502","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1213\/ANE.0000000000001812","article-title":"Clinical significance of portal hypertension diagnosed with bedside ultrasound after cardiac surgery.","volume":"124","author":"Denault","year":"2017","journal-title":"Anesth Analg"},{"key":"R35-20250502","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0735-1097(93)90683-R","article-title":"Effects of adenosine in combination with calcium channel blockers in patients with primary pulmonary hypertension.","volume":"21","author":"Inbar","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"R36-20250502","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0735-1097(98)00361-1","article-title":"Inhaled nitric oxide in primary pulmonary hypertension: a safe and effective agent for predicting response to nifedipine.","volume":"32","author":"Ricciardi","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"R37-20250502","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1016\/j.transproceed.2008.03.162","article-title":"Potential for pulmonary protection by nebulized milrinone during warm ischemia.","volume":"40","author":"Chen","year":"2008","journal-title":"Transplant Proc"},{"key":"R38-20250502","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1067\/mtc.2003.107","article-title":"Inhaled epoprostenol (prostacyclin) and pulmonary hypertension before cardiac surgery.","volume":"125","author":"Hach\u00e9","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R39-20250502","doi-asserted-by":"crossref","first-page":"474","DOI":"10.4103\/1687-7934.172666","article-title":"Cardiovascular effects of prolonged milrinone inhalation in patients with pulmonary hypertension undergoing mitral valve replacement.","volume":"8","author":"Sultan","year":"2015","journal-title":"Ain-Shams J Anaesthesiol"},{"key":"R40-20250502","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1007\/s00380-017-1023-2","article-title":"A retrospective comparison of inhaled milrinone and iloprost in post-bypass pulmonary hypertension.","volume":"32","author":"Theodoraki","year":"2017","journal-title":"Heart Vessels"},{"key":"R41-20250502","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/1089253214532375","article-title":"Pathophysiology of cardiopulmonary bypass: current strategies for the prevention and treatment of anemia, coagulopathy, and organ dysfunction.","volume":"18","author":"Esper","year":"2014","journal-title":"Semin Cardiothorac Vasc Anesth"},{"key":"R42-20250502","doi-asserted-by":"crossref","first-page":"S3281","DOI":"10.21037\/jtd.2018.08.115","article-title":"Targeting optimal blood pressure monitoring: what\u2019s next?","volume":"10","author":"Denault","year":"2018","journal-title":"J Thorac Dis"},{"key":"R43-20250502","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s12630-020-01832-z","article-title":"A proposed algorithm for combining transcranial Doppler ultrasound monitoring with cerebral and somatic oximetry: a case report.","volume":"68","author":"Azzam","year":"2021","journal-title":"Can J Anaesth"},{"key":"R44-20250502","doi-asserted-by":"crossref","first-page":"e01532","DOI":"10.1213\/XAA.0000000000001532","article-title":"Right ventricular outflow tract obstruction in the intensive care unit: a case report of 2 patients.","volume":"15","author":"Zeng","year":"2021","journal-title":"A A Pract"},{"key":"R45-20250502","doi-asserted-by":"crossref","first-page":"40S","DOI":"10.1016\/j.jacc.2004.02.032","article-title":"Diagnosis and differential assessment of pulmonary arterial hypertension.","volume":"43","author":"Barst","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R46-20250502","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.jvca.2013.03.016","article-title":"Is patient-prosthesis mismatch a perioperative predictor of long-term mortality after aortic valve replacement?","volume":"27","author":"Bianco","year":"2013","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R47-20250502","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1053\/j.jvca.2018.08.190","article-title":"Pulmonary-systemic pressure ratio correlates with morbidity in cardiac valve surgery.","volume":"33","author":"Schubert","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R48-20250502","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.4254\/wjh.v8.i32.1384","article-title":"Systemic-to-pulmonary artery pressure ratio as a predictor of patient outcome following liver transplantation.","volume":"8","author":"Rebel","year":"2016","journal-title":"World J Hepatol"},{"key":"R49-20250502","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.jvca.2017.09.017","article-title":"Heart Transplantation in patients >60 years: importance of relative pulmonary hypertension and right ventricular failure on midterm survival.","volume":"32","author":"Bianco","year":"2018","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R50-20250502","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/00000539-200112000-00018","article-title":"The additive pulmonary vasodilatory effects of inhaled prostacyclin and inhaled milrinone in postcardiac surgical patients with pulmonary hypertension.","volume":"93","author":"Haraldsson s","year":"2001","journal-title":"Anesth Analg"},{"key":"R51-20250502","doi-asserted-by":"crossref","first-page":"127","DOI":"10.5152\/TJAR.2019.91145","article-title":"Does inhaled milrinone facilitate weaning from cardiopulmonary bypass in children with congenital heart diseases complicated with pulmonary arterial hypertension?","volume":"48","author":"Elbaser","year":"2020","journal-title":"Turk J Anaesthesiol Reanim"},{"key":"R52-20250502","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1053\/j.jvca.2021.11.005","article-title":"Inhaled pulmonary vasodilator utilization and cost following initiation of a protocol in a quaternary academic heart center intensive care unit.","volume":"36","author":"Austin","year":"2022","journal-title":"J Cardiothorac Vasc Anesth"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000006192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:31:09Z","timestamp":1786113069000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000006192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,19]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000006192","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,19]]}}}